Proteus Digital Health’s ingestible sensor, an adherence tool that’s been successfully tested before in patients with diabetes and heart failure, also has utility for those on psych meds, a study ...
Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community. Among the featured data presented at this week’s International ...
Proteus Digital Health gained FDA de novo clearance for a new ingestible sensor designed to be combined with a drug, capping a four-year process of working with regulators to find the best approval ...
Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...
Proteus’s sensors attach to the pills patients swallow-and then tell doctors how their bodies respond.. Yudi Ela; Prop styling: Astrid Chastka/Hello Artists Many people forget to take their pills or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results